Global Cancer Drugs Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
- Published Date: 2021-03-20
- Report ID: 72003
- Pages: 145
-
Format:
Summary
World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.
Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.
XYZResearchs analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.
This research report indicated that the global Cancer Drugs market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. In terms of the export, China occupied more than XX % export market share in 2019, India occupied XX %. XXX is the second largest region around the world, it occupied about XX % export market share in 2019. In terms of the Local Capacity, XXX is the largest region around the world, it occupied about XX % export market share in 2019.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Cancer Drugs Market byPrudent Markets Include
China
EU
North America
Japan
India
Southeast Asia
South America
Middle East and Africa
Competitive Analysis; Who are the Major Players in Cancer Drugs Market
Roche
Novartis
Celgene
Bristol-Myers Squibb
Amgen
Johnson & Johnson
Pfizer
Takeda
Eli Lilly
AstraZeneca
Astellas
Merck & Co.
Sanofi
Bayer
Biogen Idec
Eisai
Teva
Otsuka
Merck KGaA
Ipsen
AbbVie
Gilead Sciences
...
Major Type of Cancer Drugs Covered inPrudent Markets report:
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy (Biologic Therapy)
Others
Application Segments Covered inPrudent Markets Market
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other Cancers
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Cancer Drugs Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Chemotherapy -Product Introduction and Major Manufacturers
1.1.2 Targeted Therapy -Product Introduction and Major Manufacturers
1.1.3 Immunotherapy -Product Introduction and Major Manufacturers
1.1.4 Hormonal Therapy (Biologic Therapy) -Product Introduction and Major Manufacturers
1.1.5 Others -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
2.1 China Cancer Drugs Status and Prospect (2015-2026)
2.1.1 China Cancer Drugs Market Size and Growth Rate (2015-2026)
2.1.2 China Cancer Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.2 EU Cancer Drugs Status and Prospect (2015-2026)
2.2.1 EU Cancer Drugs Market Size and Growth Rate (2015-2026)
2.2.2 EU Cancer Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.3 USA Cancer Drugs Status and Prospect (2015-2026)
2.3.1 USA Cancer Drugs Market Size and Growth Rate (2015-2026)
2.3.2 USA Cancer Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.4 Japan Cancer Drugs Status and Prospect (2015-2026)
2.4.1 Japan Cancer Drugs Market Size and Growth Rate (2015-2026)
2.4.2 Japan Cancer Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.5 India Cancer Drugs Status and Prospect (2015-2026)
2.5.1 India Cancer Drugs Market Size and Growth Rate (2015-2026)
2.5.2 India Cancer Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.6 Southeast Asia Cancer Drugs Status and Prospect (2015-2026)
2.6.1 Southeast Asia Cancer Drugs Market Size and Growth Rate (2015-2026)
2.6.2 Southeast Asia Cancer Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America Cancer Drugs Status and Prospect (2015-2026)
2.7.1 South America Cancer Drugs Market Size and Growth Rate (2015-2026)
2.7.2 South America Cancer Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 Cancer Drugs Status and Prospect (2015-2026)
2.8.1 Cancer Drugs Market Size and Growth Rate (2015-2026)
2.8.2 Cancer Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Cancer Drugs Market Assessment by Segment
3.1 Global Cancer Drugs Capacity and Growth Rate
3.2 Global Cancer Drugs Sales by Type
3.3 Global Cancer Drugs Sales Revenue by Type
3.4 Global Cancer Drugs Consumption by Application
4 Global Cancer Drugs Market Assessment by Regions
4.1 Global Cancer Drugs Production Analysis and Forecast by Regions (2015-2026)
4.2 Global Cancer Drugs Sales Analysis and Forecast by Regions (2015-2026)
4.3 Global Cancer Drugs Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
5.1 Cancer Drugs Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream
5.2 COVID-19 Impact on Cancer Drugs Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation
5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material
5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors
6 Competitive Landscape
6.1 Global Cancer Drugs Capacity Market Share of Manufacturers (2019-2020)
6.2 Global Cancer Drugs Sales Market Share of Manufacturers (2019-2020)
6.3 Global Cancer Drugs Sales Revenue Market Share of Manufacturers (2019-2020)
7 Cancer Drugs Competitive Analysis
7.1 Roche
7.1.1 Roche Company Profiles
7.1.2 Roche Product Introduction
7.1.3 Roche Cancer Drugs Production, Revenue (2015-2020)
7.1.4 SWOT Analysis
7.2 Novartis
7.2.1 Novartis Company Profiles
7.2.2 Novartis Product Introduction
7.2.3 Novartis Cancer Drugs Production, Revenue (2015-2020)
7.2.4 SWOT Analysis
7.3 Celgene
7.3.1 Celgene Company Profiles
7.3.2 Celgene Product Introduction
7.3.3 Celgene Cancer Drugs Production, Revenue (2015-2020)
7.3.4 SWOT Analysis
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Company Profiles
7.4.2 Bristol-Myers Squibb Product Introduction
7.4.3 Bristol-Myers Squibb Cancer Drugs Production, Revenue (2015-2020)
7.4.4 SWOT Analysis
7.5 Amgen
7.5.1 Amgen Company Profiles
7.5.2 Amgen Product Introduction
7.5.3 Amgen Cancer Drugs Production, Revenue (2015-2020)
7.5.4 SWOT Analysis
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Company Profiles
7.6.2 Johnson & Johnson Product Introduction
7.6.3 Johnson & Johnson Cancer Drugs Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
7.7 Pfizer
7.7.1 Pfizer Company Profiles
7.7.2 Pfizer Product Introduction
7.7.3 Pfizer Cancer Drugs Production, Revenue (2015-2020)
7.7.4 SWOT Analysis
7.8 Takeda
7.8.1 Takeda Company Profiles
7.8.2 Takeda Product Introduction
7.8.3 Takeda Cancer Drugs Production, Revenue (2015-2020)
7.8.4 SWOT Analysis
7.9 Eli Lilly
7.9.1 Eli Lilly Company Profiles
7.9.2 Eli Lilly Product Introduction
7.9.3 Eli Lilly Cancer Drugs Production, Revenue (2015-2020)
7.9.4 SWOT Analysis
7.10 AstraZeneca
7.10.1 AstraZeneca Company Profiles
7.10.2 AstraZeneca Product Introduction
7.10.3 AstraZeneca Cancer Drugs Production, Revenue (2015-2020)
7.10.4 SWOT Analysis
7.11 Astellas
7.12 Merck & Co.
7.13 Sanofi
7.14 Bayer
7.15 Biogen Idec
7.16 Eisai
7.17 Teva
7.18 Otsuka
7.19 Merck KGaA
7.20 Ipsen
7.21 AbbVie
7.22 Gilead Sciences
8 Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
